Crispr Therapeutics Ag (CRSP)

Net Income

-$451.14M

TTM · Period ending: · USD

CRSP logo

CRSP Net Income

Latest reported-$451.14M
CRSP TTM Net Income (-$25.52M → -$451.14M)
High-resolution chart · PNG

CRSP net income history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag Net Income — Trailing twelve months (TTM) (USD)
Period endingNet Income (USD)
-451,139,000
-568,534,000
-581,599,000
-488,297,000
-467,798,000
-385,657,000
-366,252,000
-239,594,000
-265,804,000
-217,136,000
-153,610,000
-353,532,000
-415,929,000
-524,023,000
-650,175,000
-680,848,000
-633,452,000
311,607,000
377,661,000
411,870,000
446,584,000
-392,297,000
-348,865,000
-211,284,000
19,578,000
45,535,000
66,858,000
-11,274,000
-200,408,000
-185,089,000
-164,981,000
-117,250,000
-91,246,000
-75,181,000
-68,356,000
-51,399,000
-41,386,000
-36,235,000
-23,202,000
-52,586,000
-44,246,000
-30,725,000
-25,520,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.